A bill for an act relating to the right to contraception.
SF 2057 would create a new Iowa statutory “Right to Contraception Act.” The bill declares that access to contraception is a fundamental right tied to privacy, health, dignity, liberty, and equality, and it makes extensive legislative findings citing U.S. Supreme Court precedent, international human-rights principles, and public-health benefits. It defines contraception broadly to include contraceptive drugs and devices, fertility-awareness-based methods, sterilization procedures, emergency contraception, and long-acting reversible contraceptives.
The bill gives individuals a statutory right to obtain and use contraceptives and gives health care providers a corresponding right to provide contraceptives and contraception-related information. It bars state and local governments from enforcing laws, rules, or standards in a way that prohibits or restricts FDA-approved contraceptives, blocks assistance in obtaining them, or makes them harder to sell, provide, obtain, or use. It also sets a strong legal standard for defending any restriction, requiring clear and convincing evidence that the restriction significantly advances safety and cannot be achieved through a less restrictive alternative. The bill further authorizes enforcement actions by the attorney general and private lawsuits by affected persons, including patients and providers, with injunctive relief and attorney-fee shifting for prevailing plaintiffs.
If enacted, the bill would add a new chapter to Iowa Code establishing statutory protections for contraception and limiting how state agencies and political subdivisions may regulate access to FDA-approved contraceptives. It would create a private right of action and attorney general enforcement authority, and it would allow courts to invalidate conflicting limitations or requirements. The bill expressly states that it does not alter insurance coverage mandates and does not authorize nonconsensual sterilization, but it would significantly constrain future state or local measures that single out contraception or impede access to it.
The available context suggests the bill is framed positively by its sponsor as a protective, public-health measure responding to concerns about post-Dobbs restrictions and efforts to narrow access to reproductive health care. The bill’s findings emphasize broad support for contraception as essential health care and a human-rights issue, indicating an intent to affirm and safeguard existing access rather than create a new regulatory burden. No committee transcript or vote record was provided, so there is no documented opposition or recorded sentiment from debate in the supplied materials.
The main points of contention are likely to be the bill’s breadth and its effect on state and local regulatory authority. The strongest protections are aimed at preventing any law that expressly, implicitly, or effectively singles out contraception or impedes access, which could be viewed by opponents as limiting the state’s ability to regulate health and safety. Another likely issue is the bill’s inclusion of sterilization within the definition of contraception and its strong litigation provisions, including attorney-fee shifting and a clear-and-convincing-evidence defense standard. Supporters would likely emphasize privacy, reproductive autonomy, and access to care, while critics may focus on preemption of future restrictions and the scope of judicial enforcement.